293 related articles for article (PubMed ID: 17626040)
1. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial.
Piepers S; Van den Berg-Vos R; Van der Pol WL; Franssen H; Wokke J; Van den Berg L
Brain; 2007 Aug; 130(Pt 8):2004-10. PubMed ID: 17626040
[TBL] [Abstract][Full Text] [Related]
2. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy.
Nobile-Orazio E; Meucci N; Barbieri S; Carpo M; Scarlato G
Neurology; 1993 Mar; 43(3 Pt 1):537-44. PubMed ID: 8450997
[TBL] [Abstract][Full Text] [Related]
3. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].
Léger JM; Viala K; Maisonobe T; Bouche P
Bull Acad Natl Med; 2007 Oct; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.
Léger JM; Chassande B; Musset L; Meininger V; Bouche P; Baumann N
Brain; 2001 Jan; 124(Pt 1):145-53. PubMed ID: 11133794
[TBL] [Abstract][Full Text] [Related]
5. IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy.
Yuki N; Watanabe H; Nakajima T; Späth PJ
J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):87-91. PubMed ID: 20667861
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.
Umapathi T; Hughes RA; Nobile-Orazio E; Léger JM
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD003217. PubMed ID: 25739040
[TBL] [Abstract][Full Text] [Related]
7. IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN.
Piepers S; Jansen MD; Cats EA; van Sorge NM; van den Berg LH; van der Pol WL
J Neuroimmunol; 2010 Dec; 229(1-2):256-62. PubMed ID: 20920831
[TBL] [Abstract][Full Text] [Related]
8. Long term follow up of multifocal motor neuropathy with conduction block under treatment.
Azulay JP; Rihet P; Pouget J; Cador F; Blin O; Boucraut J; Serratrice G
J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):391-4. PubMed ID: 9120457
[TBL] [Abstract][Full Text] [Related]
9. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment.
Van den Berg-Vos RM; Franssen H; Wokke JH; Van den Berg LH
Brain; 2002 Aug; 125(Pt 8):1875-86. PubMed ID: 12135977
[TBL] [Abstract][Full Text] [Related]
10. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study.
Van den Berg LH; Kerkhoff H; Oey PL; Franssen H; Mollee I; Vermeulen M; Jennekens FG; Wokke JH
J Neurol Neurosurg Psychiatry; 1995 Sep; 59(3):248-52. PubMed ID: 7673950
[TBL] [Abstract][Full Text] [Related]
11. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study.
Azulay JP; Blin O; Pouget J; Boucraut J; Billé-Turc F; Carles G; Serratrice G
Neurology; 1994 Mar; 44(3 Pt 1):429-32. PubMed ID: 8145910
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin infusion in multifocal demyelinating motor neuropathy: a case report.
Lin YY; Tsai CP; Ting YC; Lin KP; Liao KK; Kao KP; Wang SJ
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jul; 56(1):66-9. PubMed ID: 7553414
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy.
Gorson KC; Amato AA; Ropper AH
Neurology; 2004 Aug; 63(4):715-7. PubMed ID: 15326250
[TBL] [Abstract][Full Text] [Related]
15. Multifocal motor neuropathy with conduction block: current issues in diagnosis and treatment.
Nagale SV; Bosch EP
Semin Neurol; 2003 Sep; 23(3):325-34. PubMed ID: 14722828
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intravenous immunoglobulin in multifocal motor neuropathy.
Vlam L; Cats EA; Willemse E; Franssen H; Medic J; Piepers S; Veldink JH; van den Berg LH; van der Pol WL
J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1145-8. PubMed ID: 24336791
[TBL] [Abstract][Full Text] [Related]
17. Multifocal motor neuropathy: current concepts and controversies.
Nobile-Orazio E; Cappellari A; Priori A
Muscle Nerve; 2005 Jun; 31(6):663-80. PubMed ID: 15770650
[TBL] [Abstract][Full Text] [Related]
18. Multifocal motor neuropathy: the diagnostic spectrum and response to treatment.
Slee M; Selvan A; Donaghy M
Neurology; 2007 Oct; 69(17):1680-7. PubMed ID: 17954783
[TBL] [Abstract][Full Text] [Related]
19. [Long-term maintenance therapy of multifocal motor neuropathy by weekly administration of human immunoglobulin].
Shiratori M; Saitou K; Inukai A; Aoki S; Sobue G
Rinsho Shinkeigaku; 1996 Jun; 36(6):793-6. PubMed ID: 8937205
[TBL] [Abstract][Full Text] [Related]
20. [Lower motor neuron disease and signs of dysimmunity].
Azulay JP; Attarian S; Boucraut J; Pouget J
Rev Neurol (Paris); 2000 Apr; 156(4):372-9. PubMed ID: 10795014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
